CureVac Net Receivables from 2010 to 2026
| 5CV Stock | EUR 3.91 0.00 0.00% |
Net Receivables | First Reported 2019-12-31 | Previous Quarter 409 K | Current Value 19.6 M | Quarterly Volatility 18.9 M |
Check CureVac NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CureVac NV's main balance sheet or income statement drivers, such as Tax Provision of 34.6 M, Net Interest Income of 14.9 M or Interest Income of 7.3 M, as well as many indicators such as Price To Sales Ratio of 1.51, Dividend Yield of 0.0 or PTB Ratio of 1.16. CureVac financial statements analysis is a perfect complement when working with CureVac NV Valuation or Volatility modules.
CureVac | Net Receivables |
The Net Receivables trend for CureVac NV offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether CureVac NV is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest CureVac NV's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of CureVac NV over the last few years. It is CureVac NV's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CureVac NV's overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
CureVac Net Receivables Regression Statistics
| Arithmetic Mean | 9,540,537 | |
| Geometric Mean | 8,108,677 | |
| Coefficient Of Variation | 51.78 | |
| Mean Deviation | 4,225,283 | |
| Median | 6,858,000 | |
| Standard Deviation | 4,939,705 | |
| Sample Variance | 24.4T | |
| Range | 17.5M | |
| R-Value | 0.56 | |
| Mean Square Error | 18T | |
| R-Squared | 0.31 | |
| Significance | 0.02 | |
| Slope | 543,977 | |
| Total Sum of Squares | 390.4T |
CureVac Net Receivables History
About CureVac NV Financial Statements
CureVac NV stakeholders use historical fundamental indicators, such as CureVac NV's Net Receivables, to determine how well the company is positioned to perform in the future. Although CureVac NV investors may analyze each financial statement separately, they are all interrelated. For example, changes in CureVac NV's assets and liabilities are reflected in the revenues and expenses on CureVac NV's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CureVac NV. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 16.2 M | 12.4 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.